A phase II study of combined 5-fluoroura
β
Willy Mattsson; Finn Von Eyben; Lennart Hallsten; GΓΆran Bjelkengren
π
Article
π
1982
π
John Wiley and Sons
π
English
β 340 KB
π 2 views
In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c